Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter

Abroad (travel likely)Recruiting

Conditions

Fatty Liver

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Prince of Wales Hospital, Hong Kong, Hong Kong
Contact: Study coordinator (Vincent Wong, MD) · wongv@cuhk.edu.hk · +85235054205
Contact: Study coordinator (Angel Chim, MSc) · angelchim@cuhk.edu.hk · +85235054205

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients

Non-alcoholic Fatty Liver Disease (NAFLD) · Alcoholic Liver Disease (ALD) · Liver Fibrosis

Abroad (travel likely)Recruiting

Angers, France · Angers, France

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Non-alcoholic Fatty Liver Disease

Abroad (travel likely)RecruitingPHASE3

Arcadia, United States · Covina, United States

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

Liver Neoplasm · HBV Infection · Non-alcoholic Fatty Liver Disease NAFLD

Abroad (travel likely)Recruiting

Guangzhou, China

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

MASLD · MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) · NAFLD

Abroad (travel likely)Recruiting

La Jolla, United States